122 related articles for article (PubMed ID: 310812)
1. Effector and suppressor lymphoid cells in tumor-bearing guinea-pigs.
Berczi I; Sehon AH
Int J Cancer; 1979 Feb; 23(2):274-82. PubMed ID: 310812
[No Abstract] [Full Text] [Related]
2. Blocking of syngeneic effector T cells by soluble tumour antigens.
Plata F; Levy JP
Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
[No Abstract] [Full Text] [Related]
3. Immunological enhancement of murine tumor isografts mediated by RNA from lymphoid organs of xenogeneic immunized animals.
Pilch YH; Ramming KP
Transplantation; 1971 Jan; 11(1):10-9. PubMed ID: 5549469
[No Abstract] [Full Text] [Related]
4. Evidence for in vivo protection against a rat sarcoma by allogeneic spleen lymphocytes.
Scharovsky GO; Dlugovitzky DG; Morini JC; Londner MV
Experientia; 1978 Oct; 34(10):1366-7. PubMed ID: 738428
[No Abstract] [Full Text] [Related]
5. Identification of the principal cell type yielding immune RNA capable of transferring tumor-specific cellular cytotoxicity.
Wang BS; Onikul SR; Mannick JA
Cell Immunol; 1978 Aug; 39(1):27-35. PubMed ID: 699059
[No Abstract] [Full Text] [Related]
6. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.
Cohen AM; Burdick JF; Ketcham AS
J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095
[No Abstract] [Full Text] [Related]
7. Rejection of tumor cells in vitro: a T-cell-mediated reaction.
Berczi I; Sehon AH
Int J Cancer; 1975 Oct; 16(4):665-74. PubMed ID: 1080753
[TBL] [Abstract][Full Text] [Related]
8. The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.
Bowlin TL; Proffitt MR
Cancer Immunol Immunother; 1982; 13(1):30-7. PubMed ID: 6984353
[TBL] [Abstract][Full Text] [Related]
9. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
10. Cytotoxic T lymphocyte membrane components: an analysis of structures related to function.
Kimura AK; Wigzell H
Contemp Top Mol Immunol; 1977; 6():209-44. PubMed ID: 161527
[No Abstract] [Full Text] [Related]
11. Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis.
Leclerc JC; Gomard E; Plata F; Levy JP
Int J Cancer; 1973 Mar; 11(2):426-32. PubMed ID: 4545387
[No Abstract] [Full Text] [Related]
12. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth in the guinea pig: alpha globulin changes associated with lymphocyte suppression.
Lilley DP; Burger DR; Vetto RM
J Natl Cancer Inst; 1974 Sep; 53(3):701-9. PubMed ID: 4138027
[No Abstract] [Full Text] [Related]
15. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice.
Cruse JM; Dulaney AD
Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165
[No Abstract] [Full Text] [Related]
16. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
Nelson K; Pollack SB; Hellström KE
Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
Veit BC; Feldman JD
Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
[TBL] [Abstract][Full Text] [Related]
18. Rejection of tumor cells in vitro.
Berczi I; Strausbauch P; Sehon AH
Science; 1973 Jun; 180(4092):1289-91. PubMed ID: 4122513
[TBL] [Abstract][Full Text] [Related]
19. Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.
Kimura H; Aoki T
Br J Cancer; 1978 Apr; 37(4):553-65. PubMed ID: 206273
[TBL] [Abstract][Full Text] [Related]
20. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. II. Dynamic changes during tumor progression.
Wang WC; Berczi I; Hoffmann EG; Sehon AH
Int J Cancer; 1980 Apr; 25(4):493-501. PubMed ID: 6246008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
